Skip to main content
. 2019 Jul 1;47(7):3344–3353. doi: 10.1177/0300060519847403

Figure 3.

Figure 3.

Optimal scaling analysis of immune factors in patients with lung cancer and patients with ILD. Shorter distance between dots indicates a stronger correlation between the disease and the corresponding factor (Cronbach’s alpha = 84.7%). LC: lung cancer (n = 262), ILD: interstitial lung disease (n = 220), CER: ceruloplasmin, CRP: C-reactive protein, RF: rheumatoid factor